COMMUNIQUÉS West-GlobeNewswire

Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment
29/03/2018
NEW YORK and MELBOURNE, Australia, March 28, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today announced that enrollment has completed in the Phase 3 trial evaluating a single intra-discal [...]
Arbutus to Present HBV Data at 2018 EASL Liver Meeting
28/03/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., March 28, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]
Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April 2, 2018
28/03/2018
DURHAM, N.C., March 28, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the [...]
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update
28/03/2018
Conference call and webcast scheduled for tomorrow, March 29 at 8:30am ET GAITHERSBURG, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today [...]
Sanofi: Availability of the Pre-quarterly Results Communication
28/03/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Availability of the Pre-quarterly Results Communication Paris, France - March 28, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
28/03/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 28 mars 2018 - Sanofi annonce la mise en ligne sur l'espace [...]
Amarin to Present at the H.C. Wainwright Annual Global Life Sciences Conference
28/03/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, March 28, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results
28/03/2018
Update on MT-3724 Provided at World ADC Conference; More Data Expected in 2Q18 Upcoming Presentations at AACR Conference to Feature Data on PD-L1 Antigen Seeding ETB and HER2 ETB AUSTIN, Texas, March 28, 2018 (GLOBE [...]
Revive Therapeutics Retained Mi3 Communications for Investor Relations Services
28/03/2018
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]
HealthEquity Appoints New Director to the Board
28/03/2018
DRAPER, Utah, March 28, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the nation’s largest health savings account (HSA) non-bank custodian, today announced that its Board [...]
pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.
28/03/2018
Acquisition and additional funding significantly accelerate the company’s transformation to a specialty biopharmaceutical company with the potential to commercialize two ophthalmic products in 1H 2019 Icon Bioscience’s [...]
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
28/03/2018
BERKELEY HEIGHTS, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company") a biopharmaceutical company developing oral therapies that target [...]
Menlo Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
28/03/2018
REDWOOD CITY, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus [...]
Ascendis Pharma A/S Reports Full Year 2017 Financial Results
28/03/2018
- Rare Disease Endocrinology Pipeline Advances, with Significant Milestones Anticipated Over the Next Twelve Months - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, March 28, 2018 (GLOBE [...]
Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of ENVARSUS XR®
28/03/2018
Investor News no. 01/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 March 2018 Veloxis Announces the Publication of ASERTAA (A Study of Extended Release Tacrolimus in African-Americans), a Phase IIIb study of [...]
Northeast Scientific Receives 510K Clearance on Reprocessed RF Stylet
28/03/2018
WATERBURY, Conn., March 28, 2018 (GLOBE NEWSWIRE) -- Northeast Scientific, Inc. (NES), known for its advanced medical device reprocessing capability, received another 510K clearance from the FDA on 27 March, this time [...]
ICC Labs Announces Update to Terms of Investment with Strategic European Partner
28/03/2018
VANCOUVER, British Columbia , March 28, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ ICC Labs ” or the “ Company ”) (TSX-V: ICC ) (Frankfurt: 2Q9 ) is pleased to provide an update on its previously announced proposed [...]
OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered Products
28/03/2018
Key Clinical Portfolio Development Progress Planned for 2018 Tedopi® (neoepitopes): Phase 3 clinical trial in NSCLC – Redeployment in the U.S., Europe and Israel, based on a revised protocol focused on patients who have [...]
Essilor: 2017 Registration Document Filed
28/03/2018
2017 Registration Document Filed PDF Version of the news release Charenton-le-Pont, France (March 28, 2018 - 6:00 pm CET) - The 2017 Essilor Registration Document was filed in French version with the Autorité des [...]

Pages